Circulating cytokines associated with clinical outcomes in advanced non ‐small cell lung cancer patients who received chemoimmunotherapy

ConclusionsIn patients with advanced NSCLC who received chemoimmunotherapy, on-treatment increased IL-1 β and IFN-γ may serve as positive indicator of efficacy, while on-treatment increased IL-6 might play a predictive role of worse clinical outcome.

Source: Thoracic Cancer - November 26, 2021 Category: Cancer & Oncology Authors: Yuequan Shi, Xiaoyan Liu, Juan Du, Dongming Zhang, Jia Liu, Minjiang Chen, Jing Zhao, Wei Zhong, Yan Xu, Mengzhao Wang Tags: ORIGINAL ARTICLE Source Type: research